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Bone biology & pathology moves on: from bone 
resorption to formation, the rise of new therapeutic 
opportunities and experimental tools
Dear Readers, 
Bone comprises a complex mineralized connective 
tissue characterized by the constant remodeling, 
which involves cycles of bone resorption coupled 
with the subsequent bone formation. Also, bone 
tissue retains a considerable potential for healing, 
which also involves the cooperative action of 
bone forming and resorptive cells to restore the 
architecture and function of damaged tissue. 
However, pathological conditions such as bone 
cancer and infectious inflammatory conditions (such 
as periodontal and periapical lesions) may disturb 
the resorption/formation coupling process, resulting 
in irreversible bone destruction. 
Despite the recent huge advances on the 
understanding of bone biology and pathology, 
specially driven by the discovery of the RANK/
RANKL/OPG system, composed of molecules shared 
by bone and immunological systems (that ultimately 
resulted in the raise of the ‘osteoimmunology’ 
terminology), a series of open questions remain 
unanswered in both bone resorption and formation 
ends5. In this issue of the Journal of Applied 
Oral Science (JAOS), we are pleased to present 
examples of the evolving bone science, describing 
new therapeutic opportunities and experimental 
tools. 
Starting with the new experimental tools, 
Araujo, et al.1 (2015) use an experimental tooth 
movement model to insightfully demonstrate that 
fractal analysis can be useful in the evaluation of 
osteoclastic activity. Using classical histological 
tools to identify osteoclasts as a control, the 
authors demonstrate a positive correlation between 
osteoclasts counts and fractal dimension obtained 
with the new methodology described. Also, the 
inhibition of osteoclasts formation and activity by 
means of alendronate administration also impacted 
the fractal dimension measurement, proving the 
validity of the proposed method in a cause-and-
effect manner. 
Another important new experimental tool 
described in this issue comprises a very important 
advance in the study of mandibular bone metastasis. 
Previously in the JAOS7, a case of mandibular 
bone metastasis derived from a tumoral prostate 
adenocarcinoma was described. However, animal 
models of mandibular bone metastasis, which 
could comprise an important tool to understand 
the molecular mechanism of mandible bone 
metastasis and to develop new therapeutic agents, 
are scarce. In this context, in this issue, Hwang, 
et al.6 (2015) describe a pre-clinical mouse model 
for metastatic breast cancer to the mandible. Using 
bioluminescence, micro–computed tomography and 
histopathological analysis, the authors demonstrate 
that extensive mandibular bone destruction 
occurred in nude mice grafted with luciferase-
transfected metastatic breast cancer cells (MDA-
MB-231Luc+), and validate the new model as a 
useful tool to advance the studies on the osteolytic 
cancers field.
Moving the focus to new therapeutic opportunities, 
Saglam, et al.8 (2015) use an established 
experimental periodontitis model to demonstrate 
that Sumac (Rhus coriaria L.), a widely used 
spice, can control the progression of periodontal 
lesions. Using histometric, immunohistochemical 
and enzymatic methods, the authors demonstrate 
that the sumac extract, administered orogastrically, 
inhibits periodontitis development via the regulation 
of oxidative status and RANKL/OPG system, opening 
the opportunity to possible clinical application to 
manage periodontitis. Also, in line with previous 
reports previously published in the JAOS2,3, this 
study reinforces the central role of RANKL/OPG 
system in the pathogenesis of bacterially induced 
inflammatory osteolytic lesions, as well supports the 
validity of modulating host responses strategies to 
arrest periodontitis9. 
Finally, still in the therapeutic end, Ferraz, 
et al.4 (2015) demonstrate that plasma-nitrided 
titanium implant surfaces result in successful 
osteointegration in rabbits. By means of histological 
and histomorphometric analyses, the authors 
demonstrate that bone formation was observed in 
contact with all plasma-nitrided titanium implants; 
being such response similar to those observed in 
the positive controls. Based on the data obtained, 
the authors conclude that since plasma nitriding 
treatments improve the physico-chemical properties 
of Ti without affecting its biocompatibility, they 
could be used along with other modifications, such 
as functionalization with growth factors, to improve 
bone formation in implant therapy.
Therefore, the four studies mentioned are 
stimulating examples of the evolving bone science, 
which using new experimental tools can improve 
the understanding of the mechanisms underlying 
bone resorption and formation in physiological, 
pathological and regenerative scenarios, and apply 
this knowledge to the subsequent development 
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of new therapeutic opportunities to control tissue 
damage or promote its regeneration.  
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